Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%

March 17, 2025
VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469.24, and on March 17, 2025, the stock hit the target price of $513.76, resulting in a profit of 9.49%.

This achievement showcases the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. The market analysis leading up to this success highlighted potential factors such as positive clinical trial results, regulatory approvals, and strong financial performance driving the stock's upward trajectory.

QuantWave's automated forecasting platform provides users with opportunities to access predictions for various stocks, enabling potential profits like the one seen with VERTEX PHARMACEUTICALS INCORPORATED. For investors looking to delve deeper into QuantWave's investment strategy, QuantSchool offers a comprehensive professional investment framework. QuantSchool educates users on the key principles for generating consistent income using the QuantWave forecasting system.
If you want to leave a comment, then you need Login or Register





Other data for VRTX

Related data

VRTXAugust 15, 2025Vertex Pharmaceuticals Incorporated VRTX - Leading the Way in Rare Disease Treatments  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) continues to make headlines as a leader in developing treatments for rare diseases....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits 10.2% Profit Target Forecast by QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, with a profit of 10.2% realized....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Forecast with 8.98% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecast set by QuantWave on August 8, 2025....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock recently reached its forecasted target price of 366.54 $, generating a profit of 10.23% for investors....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Successfully Hits Price Target Forecast with 16.01% Profit: A Triumph for QuantWave's Analytics  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) recently achieved the forecasted price target, as predicted by QuantWave's automated forecasting platform on 2025-06-03....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INC Hits QuantWave Price Target with 14.91% Profit  ~2 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 14.91%....


VRTXAugust 5, 2025QuantWave Hits Bull's Eye with Vertex Pharmaceuticals Incorporated Price Target, Securing Profits of 16.13%  ~2 min.

Vertex Pharmaceuticals Incorporated, a renowned biotechnology company in the market, saw its stock price achieve a significant milestone recently as QuantWave's forecast signal on May 29, 2025, accurately predicted a short position movement. At the time of the signal, the stock was priced at $447.09, and just over two months later, on August 5, 2025, the target price of $374.98 was reached, result...


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INC: QuantWave Hits Target Forecast with Profit of 15.51%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has seen its stock hit the forecasted price target of 374.98 $ on 2025-08-05, yielding a profit of 15.51% for investors....


VRTXAugust 5, 2025QuantWave Forecast Accuracy: VERTEX PHARMACEUTICALS INC. Achieves Price Target with 15.17% Profit  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has recently hit its price target forecast as predicted by QuantWave on May 30, 2025. The forecast signal indicated a short direction with a price of $442....


VRTXAugust 5, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target with 8.91% Profit, as Forecasted by QuantWave  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the price target forecasted by QuantWave, yielding a profit of 8.91% for investors....


VRTXAugust 9, 2022Vertex Pharmaceuticals Incorporated Hits Price Target Forecast with 9.92% Profit  ~1 min.

Vertex Pharmaceuticals Incorporated (VRTX) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 9.92%....


REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with Profit of 14.62%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully achieved the price target forecast as predicted by QuantWave's automated forecasting platform....


VRTXAugust 8, 2025VERTEX PHARMACEUTICALS Stock Hits Target Price with 10.23% Profit: QuantWave Forecast Success  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED stock recently reached its forecasted target price of 366.54 $, generating a profit of 10.23% for investors....


REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 16.52% Profit  ~2 min.

REGENERON PHARMACEUTICALS, INC. stock has successfully reached the price target forecast set by QuantWave on April 4, 2025....


BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 14.06% Profit  ~1 min.

On April 14, 2025, QuantWave's forecast signal indicated a short position for BRISTOL-MYERS SQUIBB COMPANY stock, which was priced at 50.67 $....